Invivyd Inc. (NASDAQ: IVVD) announced that the first participants have been dosed in its LIBERTY Phase 3 clinical trial, which ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE